Table 2.
Group name | Genes | #Genes |
---|---|---|
Small cell carcinoma of lung | VPS13B, SLC16A1, ANXA1, CD99, SMARCC1, PCNA… | 41 |
Leukemia, B-cell | TP53, LAMA4, STK11, CSPG4, CD40, TNFRSF1A… | 43 |
Stage III breast cancer Ajcc V6 | TP53, BRCA2 | 2 |
Head and neck carcinoma | PRMT5, ANXA1, LGALS1, TIMP3, IGFBP7, PCNA, TNC, TP53… | 149 |
Secondary malignant neoplasm of bone | ADAM9, SLC16A1, CD99, NME1-NME2, DPYSL3, TNC, TP53, NRAS… | 145 |
Malignant glioma | TK1, NPAS3, CD63, HMGB1, TAGLN2, TXNIP… | 162 |
Adenocarcinoma, tubular | PCNA, TP53, EFEMP1, APOE, STK11, PRKD1… | 31 |
Childhood brain neoplasm | TP53, NRAS, SOX9, MYC, TNFRSF11B | 5 |
Adult myelodysplastic syndrome | CSNK1A1, CTNNA1, HMGB1, PCNA, TOP2A, TP53… | 58 |
Non-small cell lung cancer stage I | TP53, PRRX1, IGFBP3, VEGFA, S100A6, GSTK1… | 22 |
The last column represents the number of genes in each group (group size).